1. Home
  2. |Insights
  3. |SFIA Legal Task Force Thought Leadership: Overview & Guidance to New Proposed Mandatory CPSC Voluntary Product Recall Regulations

SFIA Legal Task Force Thought Leadership: Overview & Guidance to New Proposed Mandatory CPSC Voluntary Product Recall Regulations

Event | 03.27.14, 12:00 AM UTC - 12:00 AM UTC

Recently companies have become concerned with the CPSC's new proposed voluntary product recall process placing significant burdens on manufacturers of consumer products. Many argue that the existing voluntary recall process is an efficient and effective way of quickly addressing product safety concerns, and that these new regulations could turn the cooperative effort into an unnecessarily expensive legal struggle between the Commission and manufacturers.


Cheryl Falvey is an expert panelist.


For more information, please visit these areas: Litigation and Trial, Product Risk Management

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.